FDA — authorised 5 April 2010
- Application: NDA022272
- Marketing authorisation holder: PURDUE PHARMA LP
- Local brand name: OXYCONTIN
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
🇺🇸 OXYCONTIN® in United States
FDA authorised OXYCONTIN® on 5 April 2010
Marketing authorisations
FDA
- Status: approved
Other Pain approved in United States
Frequently asked questions
Is OXYCONTIN® approved in United States?
Yes. FDA authorised it on 5 April 2010; FDA has authorised it.
Who is the marketing authorisation holder for OXYCONTIN® in United States?
PURDUE PHARMA LP holds the US marketing authorisation.